Review



mouse anti icam1 bba3  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems mouse anti icam1 bba3
    Mouse Anti Icam1 Bba3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 110 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+icam1+bba3/Human+ICAM-1%2FCD54+Antibody/pm38693577-81-24-30
    Average 93 stars, based on 110 article reviews
    mouse anti icam1 bba3 - by Bioz Stars, 2026-08
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems mouse anti icam1 bba3
    Mouse Anti Icam1 Bba3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+icam1+bba3/Human+ICAM-1%2FCD54+Antibody/pm38693577-81-24-30
    Average 93 stars, based on 1 article reviews
    mouse anti icam1 bba3 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    R&D Systems Hematology mouse anti human icam1
    Mouse Anti Human Icam1, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+icam1+bba3/Human+ICAM-1%2FCD54+Antibody/10__1161_slash_atvbaha__117__310491-505-43-48
    Average 93 stars, based on 1 article reviews
    mouse anti human icam1 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    95
    R&D Systems anti human icam1 monoclonal mouse igg1 antibody
    A. <t>ICAM1</t> protein expression in ADAR1-p110 (dotted line) and Mock cells (black line) was analyzed by extracellular flow cytometry staining using ICAM1 monoclonal antibody. B. LFA-1 protein expression in TIL52, TIL14 and JKF6 was analyzed by extracellular flow cytometry staining using human LFA-1 alpha antibody. C. ADAR1-p110 and Mock cells were incubated with different concentrations of <t>IgG1</t> control (isotype) or ICAM1 antibody. After 1 h, cells were co-incubated with JKF6 for 9 h (E:T - 15:1). Specific lysis of melanoma cells was assessed by LDH release. Experiments were performed three times in triplicates. Flow cytometry figures show one representative experiment.
    Anti Human Icam1 Monoclonal Mouse Igg1 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+anti+icam1+bba3/Human+ICAM-1%2FCD54+Antibody/pmc04745707-236-16-22
    Average 95 stars, based on 1 article reviews
    anti human icam1 monoclonal mouse igg1 antibody - by Bioz Stars, 2026-08
    95/100 stars
      Buy from Supplier

    Image Search Results


    A. ICAM1 protein expression in ADAR1-p110 (dotted line) and Mock cells (black line) was analyzed by extracellular flow cytometry staining using ICAM1 monoclonal antibody. B. LFA-1 protein expression in TIL52, TIL14 and JKF6 was analyzed by extracellular flow cytometry staining using human LFA-1 alpha antibody. C. ADAR1-p110 and Mock cells were incubated with different concentrations of IgG1 control (isotype) or ICAM1 antibody. After 1 h, cells were co-incubated with JKF6 for 9 h (E:T - 15:1). Specific lysis of melanoma cells was assessed by LDH release. Experiments were performed three times in triplicates. Flow cytometry figures show one representative experiment.

    Journal: Oncotarget

    Article Title: A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme

    doi:

    Figure Lengend Snippet: A. ICAM1 protein expression in ADAR1-p110 (dotted line) and Mock cells (black line) was analyzed by extracellular flow cytometry staining using ICAM1 monoclonal antibody. B. LFA-1 protein expression in TIL52, TIL14 and JKF6 was analyzed by extracellular flow cytometry staining using human LFA-1 alpha antibody. C. ADAR1-p110 and Mock cells were incubated with different concentrations of IgG1 control (isotype) or ICAM1 antibody. After 1 h, cells were co-incubated with JKF6 for 9 h (E:T - 15:1). Specific lysis of melanoma cells was assessed by LDH release. Experiments were performed three times in triplicates. Flow cytometry figures show one representative experiment.

    Article Snippet: For blocking assays, target cells were pre-incubated for 1 h on ice with different concentrations of anti-Human ICAM1 monoclonal mouse IgG1 antibody (R&D Systems, cat#BBA3) or mouse IgG1 isotype control (BioXCell, cat#BE0083), followed by 9 h cytotoxicity assays.

    Techniques: Expressing, Flow Cytometry, Staining, Incubation, Control, Lysis

    A–B. 624mel cells were transfected with miR-222 precursor, mir-221 precursor or control (pQCXIP) plasmid. Expression levels were assessed by qRT-PCR and normalized to U6 expression. C–D. ICAM1 mRNA levels in miR-222 OX, miR-221 OX and pQCXIP cells were assessed by qRT-PCR and normalized to GAPDH expression. E–F. ICAM1 protein expression in miR-222 OX (dotted line) (E), miR-221 OX (dotted line) (F) and pQCXIP (black line) cells was analyzed by extracellular flow cytometry staining. G–H. miR-222 OX or miR-221 OX cells and pQCXIP cells were co-incubated in different E:T ratios with JKF6 or TIL52 for 5 h or overnight. Specific lysis of melanoma cells was assessed by flow cytometry or LDH release. I. 293T cells were co-transfected with miR-222, mir-221 or control (pQCXIP empty vector) constructs and with ICAM1 UTR or ICAM1 UTR MUT which is mutated at the predicted binding site of miR-221 and miR-222. Dual luciferase assay was carried out and Renilla luciferase activity was measured and normalized to the firefly constitutive luciferase activity. Relative Luciferase activity was normalized to the Luciferase activity of control vector. NS denotes “not significant”. Experiment was performed three times in sixplicates. J. miR-222 OX and pQCXIP cells were incubated with different concentrations of IgG1 control (isotype) or ICAM1 antibody. After 1 h, cells were co-incubated with JKF6 for 9 h (E:T - 15:1). Specific lysis of melanoma cells was assessed by LDH release. Experiments were performed three times in triplicates. Flow cytometry figures show one representative experiment.

    Journal: Oncotarget

    Article Title: A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme

    doi:

    Figure Lengend Snippet: A–B. 624mel cells were transfected with miR-222 precursor, mir-221 precursor or control (pQCXIP) plasmid. Expression levels were assessed by qRT-PCR and normalized to U6 expression. C–D. ICAM1 mRNA levels in miR-222 OX, miR-221 OX and pQCXIP cells were assessed by qRT-PCR and normalized to GAPDH expression. E–F. ICAM1 protein expression in miR-222 OX (dotted line) (E), miR-221 OX (dotted line) (F) and pQCXIP (black line) cells was analyzed by extracellular flow cytometry staining. G–H. miR-222 OX or miR-221 OX cells and pQCXIP cells were co-incubated in different E:T ratios with JKF6 or TIL52 for 5 h or overnight. Specific lysis of melanoma cells was assessed by flow cytometry or LDH release. I. 293T cells were co-transfected with miR-222, mir-221 or control (pQCXIP empty vector) constructs and with ICAM1 UTR or ICAM1 UTR MUT which is mutated at the predicted binding site of miR-221 and miR-222. Dual luciferase assay was carried out and Renilla luciferase activity was measured and normalized to the firefly constitutive luciferase activity. Relative Luciferase activity was normalized to the Luciferase activity of control vector. NS denotes “not significant”. Experiment was performed three times in sixplicates. J. miR-222 OX and pQCXIP cells were incubated with different concentrations of IgG1 control (isotype) or ICAM1 antibody. After 1 h, cells were co-incubated with JKF6 for 9 h (E:T - 15:1). Specific lysis of melanoma cells was assessed by LDH release. Experiments were performed three times in triplicates. Flow cytometry figures show one representative experiment.

    Article Snippet: For blocking assays, target cells were pre-incubated for 1 h on ice with different concentrations of anti-Human ICAM1 monoclonal mouse IgG1 antibody (R&D Systems, cat#BBA3) or mouse IgG1 isotype control (BioXCell, cat#BE0083), followed by 9 h cytotoxicity assays.

    Techniques: Transfection, Control, Plasmid Preparation, Expressing, Quantitative RT-PCR, Flow Cytometry, Staining, Incubation, Lysis, Construct, Binding Assay, Luciferase, Activity Assay

    A. ADAR1 His-tagged mRNA levels were assessed by qRT-PCR and normalized to GAPDH expression. Protein expression of ADAR1 His-tagged constructs was determined by WB using ADAR1 polyclonal antibody and polyHistidine monoclonal antibody (cut from different regions in the same membrane). B. Expression levels of hsa-miR-222 in ΔCAT-S and Mock cells were assessed by qRT-PCR and normalized to U6 expression. C. ICAM1 protein expression in ΔCAT-S (dotted line) and Mock cells (black line) was analyzed by extracellular flow cytometry staining. D. ΔCAT-S and Mock cells were co-incubated with JKF6 for 5 h (E:T - 15:1). Specific lysis of melanoma cells was assessed by flow cytometry. Experiments were performed three times in triplicates. WB and flow cytometry figures show one representative experiment.

    Journal: Oncotarget

    Article Title: A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme

    doi:

    Figure Lengend Snippet: A. ADAR1 His-tagged mRNA levels were assessed by qRT-PCR and normalized to GAPDH expression. Protein expression of ADAR1 His-tagged constructs was determined by WB using ADAR1 polyclonal antibody and polyHistidine monoclonal antibody (cut from different regions in the same membrane). B. Expression levels of hsa-miR-222 in ΔCAT-S and Mock cells were assessed by qRT-PCR and normalized to U6 expression. C. ICAM1 protein expression in ΔCAT-S (dotted line) and Mock cells (black line) was analyzed by extracellular flow cytometry staining. D. ΔCAT-S and Mock cells were co-incubated with JKF6 for 5 h (E:T - 15:1). Specific lysis of melanoma cells was assessed by flow cytometry. Experiments were performed three times in triplicates. WB and flow cytometry figures show one representative experiment.

    Article Snippet: For blocking assays, target cells were pre-incubated for 1 h on ice with different concentrations of anti-Human ICAM1 monoclonal mouse IgG1 antibody (R&D Systems, cat#BBA3) or mouse IgG1 isotype control (BioXCell, cat#BE0083), followed by 9 h cytotoxicity assays.

    Techniques: Quantitative RT-PCR, Expressing, Construct, Membrane, Flow Cytometry, Staining, Incubation, Lysis